These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34548377)

  • 1. IVIG Compared With IVIG Plus Infliximab in Multisystem Inflammatory Syndrome in Children.
    Cole LD; Osborne CM; Silveira LJ; Rao S; Lockwood JM; Kunkel MJ; MacBrayne CE; Heizer HR; Anderson MS; Jone PN; Dominguez SR
    Pediatrics; 2021 Dec; 148(6):. PubMed ID: 34548377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.
    Ouldali N; Toubiana J; Antona D; Javouhey E; Madhi F; Lorrot M; Léger PL; Galeotti C; Claude C; Wiedemann A; Lachaume N; Ovaert C; Dumortier M; Kahn JE; Mandelcwajg A; Percheron L; Biot B; Bordet J; Girardin ML; Yang DD; Grimaud M; Oualha M; Allali S; Bajolle F; Beyler C; Meinzer U; Levy M; Paulet AM; Levy C; Cohen R; Belot A; Angoulvant F;
    JAMA; 2021 Mar; 325(9):855-864. PubMed ID: 33523115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children.
    Villacis-Nunez DS; Jones K; Jabbar A; Fan L; Moore W; Peter AS; Henderson M; Xiang Y; Kelleman MS; Sherry W; Chandrakasan S; Oster ME; Jaggi P; Prahalad S
    JAMA Pediatr; 2022 Jun; 176(6):576-584. PubMed ID: 35344042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children with the multisystem inflammatory syndrome.
    Devrim İ; Böncüoğlu E; Kıymet E; Şahinkaya Ş; Çelebi MY; Cem E; Düzgöl M; Arıkan KÖ; Kara AA; Besin D; Vuran G; Seven P; Meşe T; Ağın H; Bayram N
    Pediatr Rheumatol Online J; 2022 Aug; 20(1):69. PubMed ID: 35987681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
    Son MBF; Murray N; Friedman K; Young CC; Newhams MM; Feldstein LR; Loftis LL; Tarquinio KM; Singh AR; Heidemann SM; Soma VL; Riggs BJ; Fitzgerald JC; Kong M; Doymaz S; Giuliano JS; Keenaghan MA; Hume JR; Hobbs CV; Schuster JE; Clouser KN; Hall MW; Smith LS; Horwitz SM; Schwartz SP; Irby K; Bradford TT; Maddux AB; Babbitt CJ; Rowan CM; McLaughlin GE; Yager PH; Maamari M; Mack EH; Carroll CL; Montgomery VL; Halasa NB; Cvijanovich NZ; Coates BM; Rose CE; Newburger JW; Patel MM; Randolph AG;
    N Engl J Med; 2021 Jul; 385(1):23-34. PubMed ID: 34133855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals.
    Harthan AA; Nadiger M; McGarvey JS; Hanson K; Gharpure VP; Bjornstad EC; Chiotos K; Miller AS; Reikoff RA; Gajic O; Kumar V; Walkey AJ; Kashyap R; Tripathi S;
    Pharmacotherapy; 2022 Jul; 42(7):529-539. PubMed ID: 35661394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone PN; Anderson MS; Mulvahill MJ; Heizer H; Glodé MP; Dominguez SR
    Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment.
    Abdel-Haq N; Asmar BI; Deza Leon MP; McGrath EJ; Arora HS; Cashen K; Tilford B; Charaf Eddine A; Sethuraman U; Ang JY
    Eur J Pediatr; 2021 May; 180(5):1581-1591. PubMed ID: 33452570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.
    Burns JC; Roberts SC; Tremoulet AH; He F; Printz BF; Ashouri N; Jain SS; Michalik DE; Sharma K; Truong DT; Wood JB; Kim KK; Jain S;
    Lancet Child Adolesc Health; 2021 Dec; 5(12):852-861. PubMed ID: 34715057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory Therapy for MIS-C.
    Ouldali N; Son MBF; McArdle AJ; Vito O; Vaugon E; Belot A; Leblanc C; Murray NL; Patel MM; Levin M; Randolph AG; Angoulvant F;
    Pediatrics; 2023 Jul; 152(1):. PubMed ID: 37376963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin for the treatment of Kawasaki disease.
    Broderick C; Kobayashi S; Suto M; Ito S; Kobayashi T
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014884. PubMed ID: 36695415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in Early Anakinra Use and Short-Term Outcomes in Multisystem Inflammatory Syndrome in Children.
    Chang JC; Young CC; Muscal E; Sexson Tejtel SK; Newhams MM; Kucukak S; Crandall H; Maddux AB; Rowan CM; Halasa NB; Harvey HA; Hobbs CV; Hall MW; Kong M; Aguiar CL; Schuster JE; Fitzgerald JC; Singh AR; Wellnitz K; Nofziger RA; Cvijanovich NZ; Mack EH; Schwarz AJ; Heidemann SM; Newburger JW; Zambrano LD; Campbell AP; Patel MM; Randolph AG; Son MBF;
    Arthritis Rheumatol; 2023 Aug; 75(8):1466-1476. PubMed ID: 36908050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in a Japanese child.
    Yamaguchi Y; Takasawa K; Irabu H; Hiratoko K; Ichigi Y; Hirata K; Tamura Y; Murakoshi M; Yamashita M; Nakatani H; Shimoda M; Ishii T; Udagawa T; Shimizu M; Kanegane H; Morio T
    J Infect Chemother; 2022 Jun; 28(6):814-818. PubMed ID: 35125343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NT-proBNP Levels Following IVIG Treatment of Multisystem Inflammatory Syndrome in Children.
    Schmitz A; Wood KE; Badheka A; Burghardt E; Wendt L; Sharathkumar A; Koestner B
    Hosp Pediatr; 2022 Jul; 12(7):e261-e265. PubMed ID: 35388427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatments for multi-system inflammatory syndrome in children - discharge, fever, and second-line therapies.
    Tagarro A; Domínguez-Rodríguez S; Mesa JM; Epalza C; Grasa C; Iglesias-Bouzas MI; Fernández-Cooke E; Calvo C; Villaverde S; Torres-Fernández D; Méndez-Echevarria A; Leoz I; Fernández-Pascual M; Saavedra-Lozano J; Soto B; Aguilera-Alonso D; Rivière JG; Fumadó V; Martínez-Campos L; Vivanco A; Pilar-Orive FJ; Alcalá P; Ruiz B; López-Machín A; Oltra M; Moraleda C;
    Eur J Pediatr; 2023 Jan; 182(1):461-466. PubMed ID: 36282324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin for the treatment of childhood encephalitis.
    Iro MA; Martin NG; Absoud M; Pollard AJ
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD011367. PubMed ID: 28967695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study.
    Dizon BLP; Redmond C; Gotschlich EC; Sule S; Ronis T; Vazzana KM; Sherman MA; Connor R; Bosk A; Dham N; Harahsheh AS; Wells E; DeBiasi R; Srinivasalu H
    Pediatr Rheumatol Online J; 2023 Jul; 21(1):76. PubMed ID: 37525200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Biologics in the Treatment of Multisystem Inflammatory Syndrome in Children (Mis-C): A Single-Center Propensity-Score-Matched Study.
    Basaran O; Batu ED; Kaya Akca U; Atalay E; Kasap Cuceoglu M; Sener S; Balık Z; Karabulut E; Kesici S; Karagoz T; Ozsurekci Y; Bilginer Y; Cengiz AB; Ozen S
    Children (Basel); 2023 Jun; 10(6):. PubMed ID: 37371276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial Immunomodulation and Outcome of Children with Multisystem Inflammatory Syndrome Related to COVID-19: A Multisite Study from India.
    Bagri NK; Khan M; Pandey RM; Lodha R; Kabra SK;
    Indian J Pediatr; 2022 Dec; 89(12):1236-1242. PubMed ID: 35699843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease.
    Han CL; Zhao SL
    Med Sci Monit; 2018 Oct; 24():7264-7270. PubMed ID: 30307902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.